Wells Fargo & Company »

Recro Pharma shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Recro Pharma (SCTL) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Recro Pharma

Tip: Access up to 7 years of quarterly data

All positions including Recro Pharma held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Recro Pharma by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $330 942 0.35
2023-09-30 $360 770 0.47
2023-06-30 $825 750 1.10
2022-12-31 $4.4k 2.9k 1.49
2022-09-30 $8.7k 2.9k 2.95
2022-06-30 $0 552 0.00
2022-03-31 $0 469 0.00
2021-12-31 $0 466 0.00
2021-09-30 $0 465 0.00
2021-06-30 $1.8k 456 3.91
2021-03-31 $56k 20k 2.79
2020-12-31 $61k 21k 2.86
2020-09-30 $88k 43k 2.08
2020-06-30 $358k 79k 4.57
2020-03-31 $1.7M 214k 8.17
2019-12-31 $1.9M 104k 18.32
2019-09-30 $603k 54k 11.09
2019-06-30 $526k 52k 10.17
2019-03-31 $246k 42k 5.88
2018-12-31 $975k 137k 7.14
2018-09-30 $963k 136k 7.08
2018-06-30 $877k 175k 5.01
2018-03-31 $845k 77k 11.00
2017-12-31 $487k 53k 9.22
2017-06-30 $121k 17k 7.01
2017-03-31 $150k 17k 8.73
2016-12-31 $135k 17k 8.09
2016-09-30 $276k 31k 8.84
2016-06-30 $159k 20k 7.95